Argenica Therapeutics Limited

AGN

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. The firm is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The firm's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE).

AGL Energy Limited.

AGL

AGL Energy Ltd. is an integrated renewable energy company, which engages in the provision of natural gas distribution services. The company is headquartered in Melbourne, Victoria and currently employs 3,897 full-time employees. The company went IPO on 2006-10-12. The firm's Accel-Operations segment comprises the power generation portfolio and other assets of Accel Energy. Its Accel-Trading and Origination segment consists of wholesale electricity and C&I customer portfolio of Accel. Its AGL Australia-Customer segment comprises the consumer and large business customer portfolios responsible for the retailing of electricity, gas, solar and energy efficiency products and services to residential, small and large business customers and the retailing of telecommunications. Its AGL Australia-Supply and Trading segment comprises the wholesale electricity, gas and eco markets trading and operating activities of AGL Australia. Its AGL Australia-Investments segment comprises AGL Australia's interests in the ActewAGL Retail Partnership, Tilt Renewables, Energy Impact Partners Europe, Activate Capital Partners, and other investments.